Company - Corporate Actions - Earnings

CNFinance Holdings Ltd (CNF) confirmed earnings release on May 24, 2024, Before the market for the quarter ending March 30, 2024.The estimated EPS is $0.14The estimated revenue is $69320000 ...

May 24, 2024   CNF 3.65%

Molecular Partners AG (MOLN) confirmed earnings release on May 24, 2024, Before the market for the quarter ending March 31, 2024.The estimated EPS is $-1The annoucened EPS was $-0.6The annoucened...

May 24, 2024   MOLN 0.00%

LightInTheBox Holding Co Ltd (LITB) confirmed earnings release on May 24, 2024, Before the market for the quarter ending March 30, 2024.The estimated revenue is $78492000 ...

May 23, 2024   LITB -2.34%

CNFinance Holdings Ltd (CNF) confirmed earnings release on May 24, 2024, Before the market for the quarter ending March 30, 2024.The estimated EPS is $0.14The estimated revenue is $68080000 ...

May 23, 2024   CNF 3.65%

Molecular Partners AG (MOLN) confirmed earnings release on May 24, 2024, Before the market for the quarter ending March 31, 2024.The estimated EPS is $-1 ...

May 23, 2024   MOLN 0.00%

Youdao Inc (DAO) confirmed earnings release on May 23, 2024, Before the market for the quarter ending March 31, 2024.The estimated EPS is $-0.12The estimated revenue is $186620000 ...

May 23, 2024   DAO -1.59%

Endava plc (DAVA) confirmed earnings release on May 23, 2024, Before the market for the quarter ending March 31, 2024.The estimated EPS is $0.23The estimated revenue is $222170000 ...

May 23, 2024   DAVA -0.26%

NetEase Inc (NTES) confirmed earnings release on May 23, 2024, Before the market for the quarter ending March 31, 2024.The estimated EPS is $1.88The estimated revenue is $513326617 ...

May 23, 2024   NTES 1.31%

Addex Therapeutics Ltd (ADXN) confirmed earnings release on May 23, 2024, Before the market for the quarter ending March 30, 2024. ...

May 23, 2024   ADXN 0.00%

BIONOMICS LIMITED/FI (BNOX) confirmed earnings release on May 23, 2024, Before the market for the quarter ending March 30, 2024. ...

May 23, 2024   ADXN 0.00%